secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioRestorative Therapies, Inc. (BRTX)
CIK:        0001505497
Form:       8-K
Filed at:   2026-10-09T20:05:40+00:00
Accession:  0001213900-26-108467
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

BioRestorative Therapies appoints Donald J. Currie as Class I director, filling Katharyn Field vacancy
--------------------------------------------------------------------------------

- Currie, 65, appointed effective Oct 7, 2026, to serve until the 2027 annual meeting; fills the vacancy from Katharyn Field's resignation effective Aug 31, 2026.
- Board deemed Currie independent under Nasdaq listing rules and Exchange Act Rule 10A-3; he joins the Compensation and Nominating & Corporate Governance Committees.
- Compensation: CAD $2,000 per month cash fee payable in arrears plus expense reimbursement; he will not participate in the standard non-employee director compensation program.
- Currie has served as CEO and a director of Hillcrest Energy Technologies (CSE: HEAT; OTCQB: HLRTF) since February 2010, with 30+ years in energy and public-company financing.
- No arrangement or understanding with any other person regarding the appointment; no family relationships with directors or officers and no Item 404(a) reportable transactions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1505497/000121390026108467/0001213900-26-108467-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1505497/000121390026108467/ea0305784-8k_biore.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-108467

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer